Fibromyxoid variant of endometrial stromal sarcoma with atypical bizarre nuclei by 정윤양 & 김현수
Int J Clin Exp Pathol 2015;8(3):3316-3321
www.ijcep.com /ISSN:1936-2625/IJCEP0005380
Case Report
Fibromyxoid variant of endometrial stromal sarcoma 
with atypical bizarre nuclei
Hyun-Soo Kim1*, Gun Yoon2*, Yoon Yang Jung1, Yoo-Young Lee3, Sang Yong Song4
1Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; 
2Department of Gynecology and Obstetrics, Pusan National University Yangsan Hospital, Pusan National University 
School of Medicine, Yangsan, Republic of Korea; 3Department of Obstetrics and Gynecology, Samsung Medical 
Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 4Department of Pathology and 
Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic 
of Korea. *Equal contributors.
Received December 30, 2014; Accepted February 25, 2015; Epub March 1, 2015; Published March 15, 2015
Abstract: Endometrial stromal sarcoma (ESS) is the second most common malignant uterine mesenchymal tumor. It 
affects women primarily in the perimenopausal age group. ESSs are morphologically heterogeneous. The distinction 
between uterine smooth muscle tumors such as cellular leiomyoma and myxoid leiomyosarcoma and low-grade ESS 
can be problematic when stromal sarcomas show prominent smooth muscle differentiation and abundant myxoid 
stroma, respectively. We herein present a rare case of fibromyxoid variant of ESS, which was misdiagnosed as 
hydropic leiomyoma on intraoperative frozen section examination. Grossly, the uterine mass consisted of intracavi-
tary and intramural portions. The intracavitary portion with extensive hydropic degeneration mimicked a hydropic 
leiomyoma. In contrast, the intramural portion displayed an obvious tongue-like myometrial invasion. Histologically, 
the tumor consisted of both cellular (20%) and myxoid (80%) areas. In the cellular areas, oval to spindle-shaped 
tumor cells with bland nuclear features were found to surround concentrically a rich vascular network of arterioles, 
a characteristic of ESS. In addition, two relatively well-circumscribed nodular lesions showing atypical bizarre nuclei 
were identified in the myxoid area. Immunohistochemically, the tumor cells were diffusely and strongly positive for 
CD10. The present case indicates a wide morphological spectrum of ESS. Fibromyxoid variant of ESS should be 
considered in the differential diagnosis of intracavitary and/or intramural uterine mesenchymal tumors with myxoid 
differentiation. It is important to avoid confusion between fibromyxoid ESS and myxoid leiomyosarcoma because of 
the differences in their clinical course, treatment, and prognosis.
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Introduction
Endometrial stromal sarcoma (ESS) is a malig-
nant tumor consisting of tumor cells that 
resemble endometrial stromal cells seen in 
proliferative-phase endometrium [1, 2]. Perm- 
eative, infiltrative growth into the myometrium 
and the presence of vascular invasion are the 
main characteristics of ESS [3]. In the case of 
low-grade ESS, tumor cells show relatively uni-
form and oval to fusiform nuclei surrounding a 
delicate network of arterioles, which resembles 
the endometrial spiral arterioles. Most ESSs 
show classical low-grade histologic appear-
ance similar to that mentioned above, but some 
of them may resemble other uterine mesenchy-
mal tumors since they are morphologically het-
erogeneous. For example, it can be difficult to 
distinguish ESS from cellular leiomyoma when 
low-grade ESS shows prominent smooth mus-
cle or fibroblastic differentiation [4, 5]. In such 
cases, it is important to confirm the character-
istic features of ESS, including an irregular 
tongue-like myoinvasion, vascular invasion, and 
tumor cells whirling around the spiral arterioles. 
Furthermore, ESS can exhibit sex cord-like dif-
ferentiation, mimicking a sex cord-stromal cell 
tumor of the ovary. Rhabdoid, epithelioid, or 
clear cell changes, as well as adipocytic and 
skeletal muscle differentiation, have also been 
reported in ESSs [1].
Fibromyxoid variant of ESS is a rare type of uter-
ine mesenchymal tumor. Several authors have 
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reported that the ESSs show myxoid or fibro-
myxoid changes [6-10], but their biological or 
clinical behavior still remains to be clarified. We 
herein present an extremely rare case of the 
fibromyxoid variant of ESS with atypical bizarre 
nuclei. To the best of our knowledge, only one 
case of fibromyxoid ESS with bizarre nuclei has 
been reported [10]. We describe histopatho-
logical findings of the rare variant of ESS and 
the results of the immunohistochemical study.
Clinical presentation
A 53-year-old premenopausal Korean woman 
(gravida 2, para 2) was referred to the Dep- 
artment of Obstetrics and Gynecology at 
Samsung Medical Center (Seoul, South Korea). 
Pelvic examination indicated an enlarged uter-
us consistent with a pregnancy of 12 weeks’ 
gestation. Transvaginal ultrasonography reve- 
aled multiple uterine masses. Their irregular 
contours and degenerative changes raised the 
suspicion of sarcoma. Pelvic magnetic reso-
nance imaging (MRI) scan was performed to 
clarify the existence of malignancy and to deter-
mine the therapeutic strategy. MRI scan 
revealed a uterine mass, which occupied both 
the endometrial cavity and the myometrium 
(Figure 1A). The mass was well-enhanced, with 
high signal intensity on the T2-weighted image. 
The mass seemed to be a hypervascular, infil-
trative uterine mesenchymal tumor rather than 
a benign leiomyoma. Invasion into surrounding 
organs or pelvic blood vessels was not 
observed. Bilateral ovaries were atrophic with-
out a tumorous lesion. No evidence of perito-
neal seeding or lymph node metastasis was 
observed. The uterine cervix was also free of 
tumor. Based on the imaging findings, the dif-
ferential diagnosis of the uterine mass included 
leiomyosarcoma, endometrial stromal sarco-
ma, and intravenous leiomyomatosis confined 
to the uterus. The serum levels of CA-125 and 
CA 19-9 were within their normal limits. Total 
abdominal hysterectomy was performed, and 
the specimen was sent to the Department of 
Pathology. Macroscopic examination for frozen 
section examination revealed an intracavitary 
protruding mass with myxoid and gelatinous 
appearance (Figure 1B). Microscopic examina-
tion of the mass revealed a uterine mesenchy-
mal tumor showing extensive hydropic change. 
The hypocellular tumor tissue displayed an 
edematous stroma and oval to spindle-shaped 
nuclei with mild cytologic atypia and rare mitot-
ic figures, suggestive of hydropic leiomyoma 
(Figure 1C). The operation included total abd- 
ominal hysterectomy, bilateral salpingo-oopho-
rectomy, and partial omentectomy. The postop-
erative course was uneventful, and the patient 
left the hospital 3 days later.
Pathologic findings
After formalin fixation, the intracavitary mass 
appeared as a shrunken, thin cystic wall with-
out a solid tumor component, due to extensive 
cystic degeneration (Figure 2A). Serial section-
ing of the myometrium revealed an intramural 
portion of the mass, which was not detected 
during the frozen section examination. A 
tongue-like projection with gelatinous appear-
ance and cystic change was noted in the intra-
mural portion. Based on the macroscopic view-
point, the tumor consisted of intracavitary and 
intramural portions. The intracavitary portion 
showed an extensive degenerative change, 
Figure 1. Imaging and intraoperative frozen section findings. A. Sagittal T2-weighted MRI scan revealed an infiltra-
tive, hypervascular tumor that occupied the endometrial cavity and myometrium. B. Macroscopically, the intra-
cavitary mass (white arrows) appeared to undergo extensive cystic and hydropic degeneration, resulting in a thin, 
membranous appearance, without definite evidence of a solid lesion. C. Intraoperative frozen section revealed an 
edematous stroma, suggesting extensive hydropic degeneration in a leiomyomatous nodule. The frozen section 
diagnosis was hydropic leiomyoma.
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mimicking myxoid or hydropic leiomyoma; in 
contrast, the intramural portion showed a 
tongue-like myometrial invasion, a characteris-
tic of ESS.
On microscopic examination, abundant myxoid 
or fibromyxoid matrix of the tumor was observed 
in both the intracavitary and intramural por-
tions. Hypocellular lesions with a prominent 
myxoid stroma (myxoid areas; Figure 2B) 
accounted for approximately 80% of the entire 
tumor, while scattered hypercellular lesions 
with occasional fibromyxoid stroma (cellular 
areas; Figure 2C) accounted for the remaining 
20% of the tumor. Foci of vascular invasion 
were obviously identified (Figure 2D). In the cel-
lular areas, numerous, small, thin-walled blood 
vessels resembling spiral arterioles and sur-
rounding tumor cells were clearly observed 
(Figure 2E). The majority of tumor cells had oval 
to spindle-shaped hyperchromatic nuclei with 
mild to moderate pleomorphism. The invasive 
tumor front exhibited much higher cellularity 
and obvious infiltration into the myometrium 
(Figure 2F). The mitotic rate was 3-4 and 
0-1/10 high power fields in the cellular and 
myxoid areas, respectively. In addition, in the 
myxoid area, there were two relatively well-cir-
cumscribed nodular lesions (Figure 2G), show-
ing scattered atypical bizarre cells with mark-
edly pleomorphic, hyperchromatic nuclei (Fi- 
gure 2H). No necrosis was identified.
Immunohistochemical staining was performed. 
The tumor cells of myxoid areas and invasive 
front were diffusely (more than 95%) and 
strongly positive for CD10 (Figures 2I, 2J), es- 
trogen receptor (ER), and progesterone recep-
tor (PR). The MIB-1 (Ki-67) labelling index was 
5-10% in the cellular areas and 1-5% in the 
myxoid areas. In contrast, the tumor cells were 
negative for h-caldesmon, smooth muscle 
actin, pan-cytokeratin (CK), epithelial mem-
brane antigen (EMA), S-100, and CD34. The 
bizarre cells were also positive for CD10, ER, 
and PR, but they were negative for h-caldes-
mon, smooth muscle actin, pan-CK, EMA, 
S-100, and CD34, demonstrating the same 
immunophenotype as that of the majority of 
tumor cells.
Discussion
ESS can present as either an intracavitary or 
intramural mass. The intramural ESS often 
shows nodular or diffuse myometrial perme-
ation with worm-like plugs of tumor tissue in 
the myometrial vessels. It can be accompanied 
by a cystic change, but it is rarely prominent. In 
the present case, we had difficulty in determin-
ing the uterine tumor as ESS due to the abun-
dant myxoid matrix, which is rarely observed in 
ESS. Firstly, the gross appearance of the intra-
cavitary mass mimicked a hydropic leiomyoma. 
Secondly, not examining the intramural portion 
thoroughly and only examining the intracavitary 
portion without being aware of the infiltrative 
nature of the tumor resulted in misdiagnosis on 
the intraoperative frozen section examination. 
Thirdly, microscopic examination revealed that 
the intracavitary mass showed rather bland 
nuclear features similar to those of a benign 
smooth muscle tumor, in a background of 
edematous, myxoid matrix. Nevertheless, hyd- 
ropic leiomyoma does not exhibit myometrial 
invasion; in other words, it does not show infil-
trative growth. In addition, although the tumor 
was accompanied by an extensive degenera-
tive change, an overt endometrial stromal dif-
ferentiation suggests ESS. We observed that 
the tumor cells resembling endometrial stromal 
cells were found to surround small arterioles in 
both the cellular and myxoid areas. Interestingly, 
this finding was evident at the invasive tumor 
front. Immunopositivity for CD10, ER, and PR, 
together with negativity for h-caldesmon, also 
contributed to determining the tumor as ESS.
Figure 2. Pathologic findings. (A) Macroscopically, the intracavitary portion (white arrows) appeared as a shrunken 
cystic wall after formalin fixation. Serial sectioning of the myometrium revealed an intramural mass, which was not 
identified during the frozen section examination. The intramural portion (black arrows) displayed a tongue-like pro-
jection into the myometrium and underwent cystic and myxoid changes. (B) Similar to the frozen section slide, the 
permanent section of the intracavitary portion showed hypocellular tumor tissue with abundant myxoid matrix. (C) In 
contrast, the intramural portion exhibited higher cellularity. (D) Vascular invasion was present. (E) Small arterioles, 
resembling endometrial spiral arterioles, were surrounded by tumor cells. (F) At the invasive tumor front, tumor tis-
sue infiltrated into the myometrium. These findings were typical of ESS. (G) In the myxoid area, two nodular lesions 
showing atypical bizarre nuclei were detected. (H) Scattered atypical cells displayed markedly pleomorphic, hyper-
chromatic nuclei. (I, J) Immunohistochemically, the tumor cells in the (I) fibromyxoid stroma and at the (J) invasive 
front were diffusely and strongly positive for CD10.
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Myxoid leiomyosarcoma is an important differ-
ential diagnosis, which should not be confused 
with ESS. It is a rare variant of leiomyosarcoma, 
and consists of infiltrative tumor tissue that is 
not accompanied by significant cytologic atyp-
ia. It has a low mitotic activity and shows an 
abundant myxoid matrix [11, 12]. Previous 
studies have reported that focal and weak 
staining for CD10 can be observed in myxoid 
leiomyosarcoma [11]. Therefore, it can be diffi-
cult to distinguish between fibromyxoid ESS 
and myxoid leiomyosarcoma solely based on 
the immunohistochemical staining. The two 
most important factors for differentiation 
between the two entities are as follows: firstly, 
the tumor cells with a whirling pattern, which 
surround prominent vascularization, are not 
conspicuous in myxoid leiomyosarcoma [11, 
13]. Secondly, the immunostaining result for a 
sensitive and specific marker for smooth mus-
cle differentiation, h-caldesmon, is negative in 
the case of endometrial stromal tumors includ-
ing ESS. However, the result for h-caldesmon is 
positive in leiomyosarcoma [14].
Details of the clinical behavior of fibromyxoid 
ESS have not been documented because of its 
rarity. Yilmaz and colleagues [9] reported 12 
cases of ESS, with fibromyxoid features in 7 
cases and smooth muscle differentiation in 5 
cases, and all patients with these neoplasms 
were alive with metastasis at 6-20 years. The 
authors stated that the presence of even focal 
endometrial stromal differentiation in an inva-
sive uterine mesenchymal lesion with a pre-
dominant smooth muscle, fibroblastic, or fibro-
myxoid phenotype should permit classification 
as low-grade ESS. Based on the previous cases 
reported in the literature [6, 8-10], it is likely 
that there are no differences in the survival 
time for patients who have ESS with unusual 
histological features and those with typical low-
grade ESS. Nevertheless, accumulation of 
cases with fibromyxoid ESS is necessary to elu-
cidate the clinical outcome. 
The pathogenetic mechanism and clinical impli-
cation of bizarre nuclei in ESS also remain 
unknown. To the best of our knowledge, only 
one case showing the presence of atypical cells 
with bizarre nuclei in myxoid ESS was reported. 
Kibar and colleagues [10] described that atypi-
cal bizarre cells with pleomorphic, hyperchro-
matic nuclei and large prominent nucleoli were 
observed in the endometrial curettage speci-
men. In the present case, there were two well-
circumscribed nodular lesions showing scat-
tered bizarre nuclei in the myxoid areas. The 
immunophenotype of these cells was the same 
as that of ESS cells. Since it accounts for less 
than 1% of the entire tumor volume, it is less 
likely to different clinical behavior from myxoid 
ESS showing no bizarre nuclei. No recurrence 
was detected in the previous case [10]. 
However, only two cases have been described 
so far, and further investigation on the clinical 
meaning of presence of atypical bizarre nuclei 
in myxoid or fibromyxoid ESS is necessary.
In summary, we presented an extremely rare 
case of fibromyxoid ESS with atypical bizarre 
nuclei. Such an unusual variant of ESS may 
cause diagnostic challenges, especially during 
an intraoperative frozen section diagnosis. It 
may be mistaken for myxoid leiomyosarcoma, 
hydropic or myxoid leiomyoma, or other mesen-
chymal tumors of the uterus that show a myx-
oid appearance. Clinicopathological and immu-
nohistochemical features as well as the pres-
ence of overt endometrial stromal differentia-
tion are helpful in the differential diagnosis.
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